Skip to main content
Advanced Hybrid Ablation Course

AtriCure is committed to providing the most recent and relevant education. We recognize the importance of this material as a key component in giving the HealthCare Provider (HCP) access to the knowledge and experience required to assure optimal safety and outcomes in the atrial fibrillation patient population. This section contains educational materials and activities intended to enhance the user’s experience.


The Advanced Hybrid Ablation Course was developed as a result of the published positive outcomes of Hybrid AF Convergent Therapy procedures and the FDA approval of the EPi-Sense Hybrid Coagulation system for long-standing persistent atrial fibrillation patients. This program focuses on the rationale, safety and efficacy of performing Hybrid AF Therapy.

This course faculty consists of Electrophysiologists and Cardiac Surgeons, many of whom were active in the CONVERGE IDE Trial. Attendee interaction, sharing of anecdotal experience and observations and group discussion is highly encouraged. This program is designed for Electrophysiologists, Cardiac surgeons, and Advanced Practice providers interested in the collaborative hybrid approach to treating long-standing persistent atrial fibrillation patients.

Interested In Attending? Learn More           

Endorsed by:

HRS Logo